Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 2, 2004, Pages 151-156

  Zwirska Korczala, K ^a   Berdowska, A ^a   Jochem, J ^a   Sitkiewicz, A ^a   Birkner, E ^a   Polaniak, R ^a   Jedrzejowska Szypuka H ^a   Korzonek Szlacheta, I ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Graves' disease; Hashimoto's thyroiditis; Soluble interleukin 2 receptor alpha

Indexed keywords

INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; THIAMAZOLE; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; FIBROSIS; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; THYROID DISEASE; THYROID FUNCTION; THYROIDECTOMY;

ADULT; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; FEMALE; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; METHIMAZOLE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; THYROID DISEASES; THYROIDECTOMY; THYROIDITIS, AUTOIMMUNE; THYROXINE;

EID: 1842734430     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00547.x     Document Type: Article

References (24)

1. Cohen SB, Diamantstein T, Weetman AP (1989/1990) The effect of T cell subset depletion on autoimmune thyroiditis in the Buffalo strain rat. Immunology Letters, 23, 263-268.
2. Gota̧b J, Jákobisiak M, Zagożdzon R, Obła̧kowski P. (2002) Cytokiny. In: Gołab J, Jakóbisiak M, Lasek W, ed. Immunologia PWN, Warszawa, 208-209.
3. Chrobák L (1996) Clinical significance of soluble interleukine-2 receptor. Acta Medica (Hradec Kralove), 39, 3-6.
4. Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Annals of Internal Medicine, 113, 619-627.
5. Aziz N, Nishanian P, Tatlor JM et al (1999) Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. Journal of Infectious Diseases, 179, 843-848.
6. Grüngreiff K, Reinhold D, Ansorge S (1999) Serum concentrations of sIL-2R, IL-6, TGF-β1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Cytokine, 11, 1076-1080.
7. Sawayama Y, Hayashi J, Kawakami Y et al. (1999) Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection. Digestive Diseases and Sciences, 44, 163-169.
8. Fernandez-Botran R (1991) Soluble cytokine receptors: their role in immunoregulation. The FASEB Journal, 5, 2567-2574.
9. Carotti M, Salaffi F, Feraccioli GF, Binci MC, Sartini A, Cervini C (1994) Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlation with disease activity. Rheumatology International, 14, 47-52.
10. Balázs CS. (1991) Increased level of soluble interleukin-2 receptor in sera of patients with Graves' disease. Biomedical Pharmacotherapy, 45, 311-314.
11. Koukkou E, Panayiotidis P, Alevizou-Terzaki V, Thalassinos N (1991) High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 73, 771-776.
12. Mariotti S, Caturegli P, Barbesino G, Del Prete GF, Chiovato L, Pinchera A (1991) Circulating soluble interleukin-2 receptors concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism. Journal of Endocrinological Investigation, 14, 777-781.
13. Nakanishi K, Taniguchi Y, Ohta Y (1991) Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease. Acta Endocrinologica (Copenhagen), 125, 253-258.
14. Tsatsoulis A, Vlachoyiannopoulos PG, Dalekos GN, Johnson EO, Moutsopoulos HM (1995) Increased serum interleukin-1β during treatment of hyperthyroidism with antithyroid drugs. European Journal of Clinical Investigation, 25, 654-658.
15. H1 cytokine in autoimmune thyroiditis. Immunology Letters, 71, 73-77.
16. Rasmussen AK (2000) Cytokine actions on the thyroid gland. Danish Medical Bulletin, 47, 94-114.
17. Palazzo FF, Hammond LJ, Goode AW, Mirakian R (2000) Death of the autoimmune thyrocyte: is it pushed or does it jump? Thyroid, 10, 561-572.
18. Goto Y, Itoh M, Ohta Y, Ogawa N, Goto Y, Ohashi H (1997) Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells. Thyroid, 7, 567-573.
19. Paschke R, Schurrert F, Taton M, Velu T (1994) Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. Journal of Endocrinology, 141, 309-315.
20. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JAH, Welsh KI (2000) Cytokine gene polymorphisms in autoimmune thyroid disease. Journal of Clinical Endocrinology & Metabolism, 85, 1984-1988.
21. Wiktorska J, Lewiński A, Sewerynem E (2002) Antyoksydacyjna rola propylotiouracylu. Endokrynologia Polska, 53, 357-363.
22. Signore A, Pozzili P, DiMario V, Sensi M, Beales P, Andreani D (1985) Inhibition of the receptor for interleukin-2 induced by carbimazole: relevance for the therapy of autoimmune thyroid disease. Clinical Experimental Immunology, 600, 111-115.
23. Loviselli A, Calia MA, Murenu S, Mossa P, Cambosu MA, Caradonna A (1994) Circulating soluble IL-2 receptor levels are low in patients with hypothyroid autoimmune thyroiditis. Hormones and Metabolical Research, 26, 548-551.
24. Ferretti E, Persani L, Jaffrain-Rea M-L, Giambona S, Tamburrano G, Beck-Peccoz P (1999) Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. Journal of Clinical Endocrinology & Metabolism, 84, 924-929.